Skip to content

Which way is better for reducing postoperative agitation in male patients after spine surgery, catheterization before general anesthesia or by a catheter smeared with tetracaine hydrochloride jelly after general anesthesia?

Which way is better for reducing postoperative agitation in male patients after spine surgery, catheterization before general anesthesia or by a catheter smeared with tetracaine hydrochloride jelly after general anesthesia?

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16007952
Enrollment
Unknown
Registered
2016-02-20
Start date
2016-02-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative agitation

Interventions

control group:catheterization with Paraffin oil after general anesthesia
catheterization with awake:catheterization with awake
tetracaine group:catheterization with etracaine hydrochloride jelly after general anesthesia

Sponsors

the Second Affiliated Hospital,Wenzhou Medical University,
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Select spinal surgery 90 cases of male patients undergoing elective (surgery longer than expected 2h), ASA grade I or II, aged 18 to 65 years old, weighing 40 ~ 80 kg.

Exclusion criteria

Exclusion criteria: (1) suspected to drug allergy; (2) in patients weighing more than 100kg; (3) preoperative New York Heart Association (NYHA) class III or IV persons; (4) combined heart, liver, kidney, hematopoietic system and other vital organs and systems of serious primary disease or ALT, 2 times the upper limit of normal AST, Cr exceeds upper limit of normal persons; (5) preoperative hemoglobin 160g/L, or hematocrit <30% forward; preoperative platelet count <=100*10^9/L were; preoperative coagulation prompt PT or APTT greater than the upper limit of normal 1.5 persons; (6) liquid overload, including pulmonary edema; (7) serum K +, Na + ,, Mg2 +, Cl- abnormalities; (8) with severe systemic infection; (9) associated with neurological and psychiatric disorders and unable or unwilling to co-collaborators; (10) during pregnancy, lactation or recent fertility planner; (11) within the past three months, those who participated in other clinical trials; (12) The researchers consider who not appropriate to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Heart Rate;blood pressure;AONO restlessness Rating;Catheter tolerance ratings;

Contacts

Public ContactWang Xiaocou
wangxiaocou@qq.com+86 13566236456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026